Beta Drugs Limited (NSE:BETA)
India
· Delayed Price · Currency is INR 1,696.15
-19.95 (-1.16%)
At close: Mar 10, 2025
Beta Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 410 | 364.37 | 307.19 | 248.28 | 117.25 | 94.15 | Upgrade
|
| Depreciation & Amortization | 93.55 | 90.85 | 104.1 | 72.54 | 68.74 | 37.59 | Upgrade
|
| Other Amortization | 6.97 | 6.97 | - | - | - | - | Upgrade
|
| Other Operating Activities | 8.14 | -17.12 | 19.47 | 73.18 | 38.94 | 11.99 | Upgrade
|
| Change in Accounts Receivable | -233.75 | -165.17 | -175.41 | -113.05 | -19.5 | -68.98 | Upgrade
|
| Change in Inventory | -93.2 | -191.94 | -81.37 | -64.39 | -36.96 | -28.17 | Upgrade
|
| Change in Accounts Payable | 124.66 | 190.33 | 82.88 | 114.58 | 60.05 | 13.72 | Upgrade
|
| Change in Other Net Operating Assets | -64.6 | 31.01 | -23.04 | -34.86 | -42.52 | 23.85 | Upgrade
|
| Operating Cash Flow | 251.78 | 309.3 | 233.83 | 296.28 | 186 | 84.14 | Upgrade
|
| Operating Cash Flow Growth | -9.10% | 32.28% | -21.08% | 59.29% | 121.07% | 7405.68% | Upgrade
|
| Capital Expenditures | -117.25 | -116.16 | -182.12 | -194.28 | -57.56 | -152.98 | Upgrade
|
| Investment in Securities | 0 | 7.79 | - | - | -4.27 | - | Upgrade
|
| Other Investing Activities | 12.93 | 10.84 | 6.63 | 4.52 | 3.34 | 2.43 | Upgrade
|
| Investing Cash Flow | -209.53 | -139.72 | -190.69 | -217.55 | -58.48 | -150.55 | Upgrade
|
| Short-Term Debt Issued | - | - | 43.14 | 12.14 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 6.08 | 8.14 | 37.98 | Upgrade
|
| Total Debt Issued | 77.56 | - | 43.14 | 18.22 | 8.14 | 37.98 | Upgrade
|
| Short-Term Debt Repaid | - | -41.11 | - | - | -61.08 | -12.27 | Upgrade
|
| Long-Term Debt Repaid | - | -5.59 | -43.73 | - | - | - | Upgrade
|
| Total Debt Repaid | -41.72 | -46.7 | -43.73 | - | -61.08 | -12.27 | Upgrade
|
| Net Debt Issued (Repaid) | 35.84 | -46.7 | -0.59 | 18.22 | -52.94 | 25.7 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 87.43 | Upgrade
|
| Other Financing Activities | -32.76 | -28.2 | -24.15 | -27.95 | -24.2 | -25.87 | Upgrade
|
| Financing Cash Flow | 3.08 | -74.9 | -24.74 | -9.74 | -77.14 | 87.26 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | - | Upgrade
|
| Net Cash Flow | 45.33 | 94.69 | 18.4 | 68.99 | 50.38 | 20.85 | Upgrade
|
| Free Cash Flow | 134.53 | 193.15 | 51.71 | 102 | 128.44 | -68.84 | Upgrade
|
| Free Cash Flow Growth | 18.66% | 273.54% | -49.31% | -20.59% | - | - | Upgrade
|
| Free Cash Flow Margin | 4.02% | 6.53% | 2.28% | 5.55% | 11.06% | -7.58% | Upgrade
|
| Free Cash Flow Per Share | 13.99 | 20.09 | 5.38 | 10.61 | 13.36 | -7.26 | Upgrade
|
| Cash Interest Paid | 31.34 | 26.77 | 22.8 | 17.89 | 22.2 | 22.94 | Upgrade
|
| Levered Free Cash Flow | 54.67 | 134.52 | -17.57 | 0.72 | 65.3 | -75.46 | Upgrade
|
| Unlevered Free Cash Flow | 74.26 | 151.25 | -3.32 | 11.9 | 79.18 | -61.12 | Upgrade
|
| Change in Net Working Capital | 257.84 | 143.73 | 194.22 | 87.89 | 43.97 | 35.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.